"Our commitment to innovation in the realm of life sciences continues to set us apart from our competitors and cements our leadership position in the market."
— CEO Cambridge
03Detailed Report
MLAB
Mesa Laboratories Inc
Period
Q2 2025
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedJun 25, 2026
Swipe to view all report sections
Executive Summary
Mesa Laboratories Inc (MLAB) delivered a strong performance in Q2 2025, driven by an increase in revenue and significant growth in profitability. Highlighting a year-over-year revenue growth of 8.78% to $57.83 million, the company's gross profit rose to $35.46 million, reflecting a robust gross profit margin of 61.31%. Furthermore, net income surged by 378.70% to $3.43 million, showcasing the company’s enhanced operational efficiency and effectiveness in cost management. Management's emphasis on innovation and strategic acquisitions was underscored during the end-of-quarter conference call, signaling a positive outlook for future growth and value creation for shareholders.
Key Performance Indicators
Revenue
Increasing
57.83M
QoQ: -0.58% | YoY: 8.78%
Gross Profit
Increasing
35.46M
61.31% margin
QoQ: 4.79% | YoY: 10.42%
Operating Income
Increasing
3.51M
QoQ: -37.13% | YoY: 5 946.67%
Net Income
Increasing
3.43M
QoQ: 1.18% | YoY: 378.70%
EPS
Increasing
0.63
QoQ: 0.00% | YoY: 373.91%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue Growth: MLAB reported revenues of $57.83 million, up 8.78% YoY but down 0.58% QoQ.
Gross Profit: The gross profit for the quarter reached $35.46 million with a gross profit margin of 61.31%, which represents a 10.42% increase YoY, indicating improved product mix and cost control.
Operating Income: Operating income of $3.51 million displayed a massive YoY increase of 5,946.67%, reflecting previous cost-cutting measures. However, this showed a decline of 37.13% from the previous quarter.
Net Income: The net income increased significantly to $3.43 million, marking a 378.70% growth YoY, which points to enhanced profitability strategies.
Earnings Per Share: The diluted EPS surged to $0.63, a staggering increase of 373.91% compared to last year, indicating strong earnings capability relative to the number of shares outstanding.
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
57.83M
8.78%
-0.58%
Gross Profit
35.46M
10.42%
4.79%
Operating Income
3.51M
5 946.67%
-37.13%
Net Income
3.43M
378.70%
1.18%
EPS
0.63
373.91%
0.00%
Key Financial Ratios
Gross Profit Margin
Excellent
61.30%
Gross profit margin is exceptional, indicating strong pricing power and operational efficiency
Operating Profit Margin
Fair
6.07%
Operating margin is moderate, room for improvement in cost management
Net Profit Margin
Fair
5.93%
Net profit margin is moderate, room for improvement in cost management
Return on Assets
Weak
0.76%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
2.12%
Return on equity suggests inefficient capital allocation
Current Ratio
Concern
0.71
Current ratio below safe levels, potential liquidity risk
Debt to Equity
High Risk
1.38
Debt-to-equity indicates high leverage and elevated financial risk
P/E Ratio
High Growth
51.26x
Very high P/E indicates aggressive growth expectations, higher risk
Price to Book
Premium
4.35x
Trading at premium to book value, reflects strong intangibles or growth
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.